HYDROGENATED Drug Patent Profile
✉ Email this page to a colleague
When do Hydrogenated patents expire, and when can generic versions of Hydrogenated launch?
Hydrogenated is a drug marketed by Ivax Pharms and is included in two NDAs.
The generic ingredient in HYDROGENATED is ergoloid mesylates. There are four drug master file entries for this compound. Additional details are available on the ergoloid mesylates profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYDROGENATED?
- What are the global sales for HYDROGENATED?
- What is Average Wholesale Price for HYDROGENATED?
Summary for HYDROGENATED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | HYDROGENATED at DailyMed |
US Patents and Regulatory Information for HYDROGENATED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Pharms | HYDROGENATED ERGOT ALKALOIDS | ergoloid mesylates | TABLET;SUBLINGUAL | 087186-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Pharms | HYDROGENATED ERGOT ALKALOIDS | ergoloid mesylates | TABLET;SUBLINGUAL | 087185-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
